tiprankstipranks
Cannapharmarx Inc (CPMD)
OTHER OTC:CPMD
US Market
CPMD
Cannapharmarx
RESEARCH TOOLSreports
Want to see CPMD full AI Analyst Report?

Cannapharmarx (CPMD) Ratios

60 Followers

Cannapharmarx Ratios

CPMD's free cash flow for Q2 2026 was $-0.50. For the 2026 fiscal year, CPMD's free cash flow was decreased by $ and operating cash flow was $-1.37. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.04 0.04 0.04 0.07 <0.01
Quick Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Cash Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Solvency Ratio
 -0.30 -0.30 -0.32 0.16 -0.36
Operating Cash Flow Ratio
 <0.01 -0.02 -0.07 -0.13 -0.08
Short-Term Operating Cash Flow Coverage
 0.02 -0.06 -0.20 -0.32 -0.16
Net Current Asset Value
$ -36.39M$ -35.86M$ -29.63M$ -22.70M$ -22.66M
Leverage Ratios
Debt-to-Assets Ratio
 2.99 2.94 1.30 1.10 2.68
Debt-to-Equity Ratio
 -0.67 -0.68 -0.71 -1.06 -0.84
Debt-to-Capital Ratio
 -2.02 -2.17 -2.45 16.54 -5.15
Long-Term Debt-to-Capital Ratio
 -0.01 -0.02 0.00 0.00 0.00
Financial Leverage Ratio
 -0.22 -0.23 -0.55 -0.97 -0.31
Debt Service Coverage Ratio
 -0.44 -0.20 -0.71 -0.17 -0.44
Interest Coverage Ratio
 -1.19 -1.37 -1.59 -0.93 -2.28
Debt to Market Cap
 11.65 4.24 1.67 13.35 4.23
Interest Debt Per Share
 0.03 0.03 0.03 0.05 0.08
Net Debt to EBITDA
 -2.62 -6.35 -1.84 -8.94 -2.96
Profitability Margins
Gross Profit Margin
-88.82%-153.06%-357.87%0.00%0.00%
EBIT Margin
-460.58%-637.37%-931.80%0.00%0.00%
EBITDA Margin
-463.32%-238.73%-931.67%0.00%0.00%
Operating Profit Margin
-170.13%-245.77%-439.68%0.00%0.00%
Pretax Profit Margin
-666.19%-817.19%-1207.85%0.00%0.00%
Net Profit Margin
-666.19%-817.19%-1207.85%0.00%0.00%
Continuous Operations Profit Margin
-666.19%-817.19%-1207.85%0.00%0.00%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
391.58%332.50%274.71%-233.27%163.68%
Return on Assets (ROA)
-164.22%-158.60%-91.42%31.40%-157.57%
Return on Equity (ROE)
39.79%36.92%50.01%-30.35%49.19%
Return on Capital Employed (ROCE)
11.26%13.62%24.17%24.63%44.35%
Return on Invested Capital (ROIC)
28.35%35.23%62.72%-202.12%203.66%
Return on Tangible Assets
-164.22%-158.60%-91.42%31.40%-157.57%
Earnings Yield
-829.18%-323.12%-195.59%702.22%-404.23%
Efficiency Ratios
Receivables Turnover
 64.96 7.01 40.10 0.00 0.00
Payables Turnover
 0.31 0.63 0.78 0.01 0.04
Inventory Turnover
 2.46 3.09 3.77 0.06 4.30
Fixed Asset Turnover
 0.31 0.24 0.15 0.00 0.00
Asset Turnover
 0.25 0.19 0.08 0.00 0.00
Working Capital Turnover Ratio
 -0.05 -0.05 -0.04 0.00 0.00
Cash Conversion Cycle
 -1.04K -409.07 -359.05 -24.84K -8.48K
Days of Sales Outstanding
 5.62 52.05 9.10 0.00 0.00
Days of Inventory Outstanding
 148.63 118.10 96.84 6.31K 84.82
Days of Payables Outstanding
 1.19K 579.22 464.99 31.15K 8.57K
Operating Cycle
 154.25 170.15 105.94 6.31K 84.82
Cash Flow Ratios
Operating Cash Flow Per Share
 <0.01 >-0.01 >-0.01 >-0.01 >-0.01
Free Cash Flow Per Share
 <0.01 >-0.01 >-0.01 >-0.01 >-0.01
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 0.98 1.01 1.00 1.04 1.08
Dividend Paid and CapEx Coverage Ratio
 1.00 -142.98 -848.62K -28.21 -12.49
Capital Expenditure Coverage Ratio
 1.00 -142.98 -848.62K -28.21 -12.49
Operating Cash Flow Coverage Ratio
 0.01 -0.04 -0.12 -0.18 -0.10
Operating Cash Flow to Sales Ratio
 0.15 -0.58 -2.07 0.00 0.00
Free Cash Flow Yield
18.66%-23.07%-33.51%-448.42%-74.12%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.12 -0.31 -0.51 0.14 -0.25
Price-to-Sales (P/S) Ratio
 0.80 2.53 6.18 0.00 0.00
Price-to-Book (P/B) Ratio
 -0.04 -0.11 -0.26 -0.04 -0.12
Price-to-Free Cash Flow (P/FCF) Ratio
 5.36 -4.34 -2.98 -0.22 -1.35
Price-to-Operating Cash Flow Ratio
 5.28 -4.37 -2.98 -0.23 -1.46
Price-to-Earnings Growth (PEG) Ratio
 <0.01 -0.05 <0.01 >-0.01 <0.01
Price-to-Fair Value
 -0.04 -0.11 -0.26 -0.04 -0.12
Enterprise Value Multiple
 -2.79 -7.41 -2.50 -9.30 -3.38
Enterprise Value
 21.99M 24.09M 19.12M 13.46M 16.63M
EV to EBITDA
 -2.79 -7.41 -2.50 -9.30 -3.38
EV to Sales
 12.94 17.69 23.32 0.00 0.00
EV to Free Cash Flow
 86.84 -30.32 -11.27 -5.72 -10.63
EV to Operating Cash Flow
 84.99 -30.53 -11.27 -5.92 -11.48
Tangible Book Value Per Share
 -0.05 -0.05 -0.03 -0.04 -0.08
Shareholders’ Equity Per Share
 -0.05 -0.05 -0.03 -0.04 -0.08
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 <0.01 <0.01 <0.01 0.00 0.00
Net Income Per Share
 -0.02 -0.02 -0.02 0.01 -0.04
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.45 1.28 1.30 -2.34 1.64
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.56 0.70 0.73 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 -0.02 0.07 0.17 -0.62 0.17
Currency in USD